Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells
- PMID: 24587301
- PMCID: PMC3937374
- DOI: 10.1371/journal.pone.0090252
Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells
Abstract
Botulinum neurotoxins (BoNTs) are the most poisonous substances known and cause the severe disease botulism. BoNTs have also been remarkably effective as therapeutics in treating many neuronal and neuromuscular disorders. One of the hallmarks of BoNTs, particularly serotype A, is its long persistence of 2-6 months in patients at concentrations as low as fM or pM. The mechanisms for this persistence are currently unclear. In this study we determined the persistence of the BoNT/A subtypes 1 through 5 in primary rat spinal neurons. Remarkably, the duration of intracellular enzymatic activity of BoNT/A1, /A2, /A4 and /A5 was shown to be at least 10 months. Conversely, the effects of BoNT/A3 were observed for up to ∼5 months. An intermittent dosing with BoNT/E showed intracellular activity of the shorter acting BoNT/E for 2-3 weeks, followed by reoccurrence and persistence of BoNT/A-induced SNAP-25 cleavage products.
Conflict of interest statement
Figures



Similar articles
-
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.FEBS Lett. 2011 Jan 3;585(1):199-206. doi: 10.1016/j.febslet.2010.11.045. Epub 2010 Nov 30. FEBS Lett. 2011. PMID: 21126520 Free PMC article.
-
Persistence of botulinum neurotoxin action in cultured spinal cord cells.FEBS Lett. 1999 Jul 30;456(1):137-42. doi: 10.1016/s0014-5793(99)00948-5. FEBS Lett. 1999. PMID: 10452545
-
Uptake of botulinum neurotoxin into cultured neurons.Biochemistry. 2004 Jan 20;43(2):526-32. doi: 10.1021/bi0356698. Biochemistry. 2004. PMID: 14717608
-
Botulinum neurotoxin type A: Actions beyond SNAP-25?Toxicology. 2015 Sep 1;335:79-84. doi: 10.1016/j.tox.2015.07.003. Epub 2015 Jul 10. Toxicology. 2015. PMID: 26169827 Review.
-
The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond.Br J Dermatol. 2018 May;178(5):1011-1019. doi: 10.1111/bjd.16080. Epub 2018 Mar 25. Br J Dermatol. 2018. PMID: 29086923 Review.
Cited by
-
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.Toxins (Basel). 2023 Sep 8;15(9):563. doi: 10.3390/toxins15090563. Toxins (Basel). 2023. PMID: 37755989 Free PMC article. Review.
-
Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain.Int J Mol Sci. 2023 Mar 16;24(6):5690. doi: 10.3390/ijms24065690. Int J Mol Sci. 2023. PMID: 36982762 Free PMC article.
-
The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.mBio. 2018 Mar 27;9(2):e00089-18. doi: 10.1128/mBio.00089-18. mBio. 2018. PMID: 29588398 Free PMC article.
-
Embracing the Versatility of Botulinum Neurotoxins in Conventional and New Therapeutic Applications.Toxins (Basel). 2024 Jun 4;16(6):261. doi: 10.3390/toxins16060261. Toxins (Basel). 2024. PMID: 38922155 Free PMC article. Review.
-
Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity.Int J Mol Sci. 2024 Aug 17;25(16):8955. doi: 10.3390/ijms25168955. Int J Mol Sci. 2024. PMID: 39201641 Free PMC article.
References
-
- Smith LD, Sugiyama H (1988) Botulism: The Organism, Its Toxins, The Disease. Springfield, IL: Charles C. Thomas.
-
- Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol. England. pp. 325–336. - PubMed
-
- Gimenez DF, Gimenez JA (1995) The typing of botulinal neurotoxins. International journal of food microbiology 27: 1–9. - PubMed
-
- Barash JR, Arnon SS (2014) A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. J Infect Dis 209: 183–191. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical